Orchestra Financial Statements From 2010 to 2026

Orchestra BioMed Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 70.1 M 87.6 M 50.4 M Slightly volatile Short and Long Term Debt Total 9.9 M 19 M 9.9 M Pretty Stable Other Current Liabilities 5.3 M 7 M 3.7 M Slightly volatile Total Current Liabilities 16 M 18.6 M 14.8 M Slightly volatile Other Liabilities 18 M 20 M 16.3 M Slightly volatile Property Plant And Equipment Net 2.7 M 4 M 1.7 M Slightly volatile Current Deferred Revenue 4 M 4 M 5.3 M Slightly volatile Accounts Payable 3.5 M 5.9 M 2.5 M Slightly volatile Cash 22.6 M 25.6 M 20.9 M Pretty Stable Non Current Assets Total 6.2 M 8.1 M 3.6 M Slightly volatile Non Currrent Assets Other 1.7 M 1.2 M 998.1 K Slightly volatile Other Assets 0.86 0.9 445.6 K Slightly volatile Long Term Debt 9.1 M 16.4 M 7.5 M Slightly volatile Cash And Short Term Investments 62.7 M 76.8 M 46 M Slightly volatile Net Receivables 92.2 K 82.8 K 143 K Slightly volatile Common Stock Shares Outstanding 30 M 42.3 M 24.3 M Slightly volatile Short Term Investments 40 M 51.2 M 25.2 M Slightly volatile Liabilities And Stockholders Equity 70.1 M 87.6 M 50.4 M Slightly volatile Non Current Liabilities Total 34 M 24.3 M 58.4 M Slightly volatile Inventory 161 K 198.9 K 104.8 K Slightly volatile Other Current Assets 2.5 M 2.4 M 680.5 K Slightly volatile Other Stockholder Equity 242.3 M 394.2 M 157.9 M Slightly volatile Total Liabilities 45.6 M 38.9 M 72.7 M Slightly volatile Long Term Investments 1.8 M 2.9 M 856.6 K Slightly volatile Property Plant And Equipment Gross 3.6 M 5.5 M 2.3 M Slightly volatile Short and Long Term Debt 2.4 M 1.8 M 3.3 M Slightly volatile Total Current Assets 63.9 M 79.5 M 46.9 M Slightly volatile Non Current Liabilities Other 34.2 K 36 K 207.8 K Slightly volatile Short Term Debt 470.2 K 495 K 2.9 M Slightly volatile Common Stock 3.4 K 3.6 K 112.9 M Slightly volatile Property Plant Equipment 1.2 M 1.3 M 1.1 M Slightly volatile Deferred Long Term Liabilities 80 K 90 K 98.2 K Slightly volatile Capital Lease Obligations 1.7 M 2 M 2.3 M Slightly volatile
Orchestra BioMed Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Interest Income 2.1 M 3.9 M 993.6 K Slightly volatile Depreciation And Amortization 249.7 K 354.2 K 182.9 K Slightly volatile Selling General Administrative 16.9 M 27.5 M 13.5 M Slightly volatile Other Operating Expenses 44.6 M 77 M 33.5 M Slightly volatile Research Development 27.5 M 49.2 M 19.8 M Slightly volatile Cost Of Revenue 232.3 K 234.6 K 174.9 K Slightly volatile Total Operating Expenses 44.4 M 76.7 M 33.3 M Slightly volatile Reconciled Depreciation 249.7 K 354.2 K 182.9 K Slightly volatile Interest Expense 741.6 K 834.3 K 910.6 K Slightly volatile
Orchestra BioMed Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 12.8 M 12.2 M 2.9 M Slightly volatile Begin Period Cash Flow 19.8 M 35.1 M 14.2 M Slightly volatile Depreciation 249.7 K 354.2 K 182.9 K Slightly volatile Capital Expenditures 283.4 K 260.1 K 453.2 K Slightly volatile End Period Cash Flow 22.6 M 25.6 M 20.9 M Pretty Stable Change To Netincome 476.2 K 501.3 K 2.3 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Capex To Depreciation 2.05 1.08 3.0467 Slightly volatile Inventory Turnover 1.9 1.36 1.9366 Slightly volatile Days Of Inventory On Hand 193 279 201 Slightly volatile Payables Turnover 0.0803 0.0457 0.077 Slightly volatile Cash Per Share 1.6 1.63 1.8091 Pretty Stable Days Payables Outstanding 4.4 K 8.3 K 5 K Slightly volatile Income Quality 1.03 0.95 1.1147 Slightly volatile Net Debt To EBITDA 0.0979 0.1 0.4545 Slightly volatile Current Ratio 3.24 3.84 3.0913 Slightly volatile Capex Per Share 0.0161 0.009 0.0213 Slightly volatile Interest Debt Per Share 0.39 0.52 0.4285 Slightly volatile Debt To Assets 0.23 0.25 0.2346 Pretty Stable Operating Cycle 192 290 207 Slightly volatile Days Of Payables Outstanding 4.4 K 8.3 K 5 K Slightly volatile Ebt Per Ebit 1.13 1.09 1.102 Slightly volatile Quick Ratio 3.23 3.83 3.0844 Slightly volatile Cash Ratio 1.18 1.24 1.4105 Very volatile Days Of Inventory Outstanding 193 279 201 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.16 1.0317 Slightly volatile Debt Ratio 0.23 0.25 0.2346 Pretty Stable Gross Profit Margin 1.1 1.06 0.9941 Pretty Stable
Orchestra BioMed Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 223 M 273 M 259.3 M Slightly volatile Enterprise Value 208.3 M 247 M 247.4 M Very volatile

Orchestra Fundamental Market Drivers

Orchestra Upcoming Events

About Orchestra BioMed Financial Statements

Pair Trading with Orchestra BioMed

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orchestra BioMed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will appreciate offsetting losses from the drop in the long position's value.When determining whether Orchestra BioMed Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Orchestra BioMed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Orchestra Biomed Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Orchestra Biomed Holdings Stock:

How To Invest In Orchestra Details

Is Orchestra Stock a good investment? Details

What is Orchestra BioMed's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details